BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37727194)

  • 1. Extremely Elevated Prostate-Specific Antigen in Acute Prostatitis: A Case Report.
    Nepal A; Sharma P; Bhattarai S; Mahajan Z; Sharma A; Sapkota A; Sharma A
    Cureus; 2023 Aug; 15(8):e43730. PubMed ID: 37727194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions.
    Flores-Fraile MC; Padilla-Fernández BY; Valverde-Martínez S; Marquez-Sanchez M; García-Cenador MB; Lorenzo-Gómez MF; Flores-Fraile J
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
    Azab S; Osama A; Rafaat M
    Transl Androl Urol; 2012 Sep; 1(3):148-52. PubMed ID: 26816704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.
    De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F
    Urol Oncol; 2015 Oct; 33(10):424.e17-23. PubMed ID: 26162485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.
    Kehinde EO; Sheikh M; Mojimoniyi OA; Francis I; Anim JT; Nkansa-Dwamena D; Al-Awadi KA
    BJU Int; 2003 May; 91(7):618-22. PubMed ID: 12699471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience.
    Moslemi MK; Lotfi F; Tahvildar SA
    Cancer Manag Res; 2011; 3():227-31. PubMed ID: 21792331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
    Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
    J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
    Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
    Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
    Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia.
    Koseoglu RD; Erdemir F; Parlaktas BS; Filiz NO; Uluocak N; Etikan I
    Kaohsiung J Med Sci; 2007 Aug; 23(8):387-94. PubMed ID: 17666305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).
    Lokant MT; Naz RK
    Andrologia; 2015 Apr; 47(3):328-32. PubMed ID: 24620795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.
    Hochreiter WW
    Andrologia; 2008 Apr; 40(2):130-3. PubMed ID: 18336465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.
    van Iersel MP; Witjes WP; de la Rosette JJ; Oosterhof GO
    Br J Urol; 1995 Jul; 76(1):47-53. PubMed ID: 7544204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of IL-8 and IL-6 in prostatic fluid with serum prostate-specific antigen level in patients with benign prostatic hyperplasia complicated by prostatitis].
    Ren X; Wu C; Yu Q; Zhu F; Liu P; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):135-9. PubMed ID: 26806754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.